Can cannabis shed its dubious and illicit past so that this compound can be looked at within a medical framework first, and a recreational one second?
Continue readingree’ -im-burs-og-ruh-fee
Canada’s contribution to Reimbursography, GLOBALHealthPR’s (GHPR) country-specific pharma market access insights, has been published.
Continue reading2015’s Biggest PR Hits And Misses
Whoever said you that you can’t take brand equity to the bank never dealt with a knife to their reputation.
Continue reading(S)training to Understand VIA’s Loyalty Strategy
I chose VIA 1 as a guilty pleasure. It no longer is.
Continue reading